If you have been prescribed Spegra or Viropil, you may want to understand how they differ, whether one has fewer side effects, and what matters when choosing an HIV treatment.
Both are combination medicines used to treat HIV. They contain the same active ingredient, dolutegravir, but differ in their other ingredients, including the form of tenofovir they contain.
These differences may matter depending on your kidney health, bone health, other medical conditions, and treatment history. However, neither medicine is automatically better for everyone.
This guide explains Spegra vs Viropil, their composition, and the factors worth discussing with your HIV doctor.
Important: Do not stop or switch your HIV medicine without consulting your treating doctor.
Spegra vs Viropil: What Is the Difference?
The main difference between Spegra and Viropil is their combination of active ingredients.
| Active ingredient | Spegra | Viropil |
| Dolutegravir | 50 mg | 50 mg |
| Emtricitabine | 200 mg | Not included |
| Lamivudine | Not included | 300 mg |
| Tenofovir alafenamide (TAF) | 25 mg | Not included |
| Tenofovir disoproxil fumarate (TDF) | Not included | 300 mg |
Both contain three active ingredients, but two differ.
How do these ingredients work?
- Dolutegravir helps prevent HIV from integrating its genetic material into human cells.
- Emtricitabine and lamivudine interfere with an enzyme HIV uses to make copies of itself.
- TAF and TDF are different forms of tenofovir that help suppress HIV replication.
Together, these medicines help control HIV. Effective antiretroviral therapy (ART) can lower viral load and protect immune function.
Although Spegra and Viropil share dolutegravir, their different formulations mean they should not be considered automatically interchangeable.
TAF vs TDF: Does the Difference Matter?
One important difference in Spegra vs Viropil is the form of tenofovir in each tablet.
Spegra contains tenofovir alafenamide (TAF), while Viropil contains tenofovir disoproxil fumarate (TDF). Both are used in HIV treatment, but research has found differences in their effects on kidney and bone health measurements.
1. Kidney health
TDF can affect kidney function in some people. Studies generally show more favourable kidney safety markers with TAF than with TDF.
What this means for you: If you have kidney disease or a history of kidney-related side effects, ask your doctor whether your current treatment is suitable. Your kidney test results and complete medication regimen matter when making this decision.
This does not mean everyone taking TDF will develop kidney problems or that TAF has no kidney-related risks.
2. Bone health
Research has found that TDF-containing regimens can cause greater reductions in bone mineral density than TAF-containing regimens.
Bone mineral density measures the amount of mineral present in your bones. Lower density may be relevant if you have osteoporosis or an increased risk of fractures.
What this means for you: If you have osteoporosis, a history of fractures, or other bone-health concerns, discuss them with your HIV specialist.
However, better bone density measurements do not automatically mean that everyone taking TAF will experience fewer fractures.
3. Does this make Spegra better than Viropil?
Not necessarily.
Research supports differences in kidney and bone safety markers between TAF and TDF. It does not establish that Spegra is the better choice for every patient.
Some studies have also found more pronounced safety differences when TDF is combined with certain medicines, such as ritonavir or cobicistat. Neither Spegra nor Viropil includes these boosters in its listed three-drug combination.
The takeaway: Kidney and bone health are relevant when discussing TAF and TDF with your doctor, but treatment decisions must consider your overall health and medical needs.
Which Health Factors Should You Discuss With Your Doctor?
When comparing Spegra and Viropil, consider these factors during your consultation.
| Health factor | Why it matters | What to ask your doctor |
| Kidney problems | TDF may cause kidney-related side effects in some patients. | Do my kidney results affect my treatment options? |
| Bone-health concerns | TDF may have less favourable effects on bone mineral density. | Should my bone health influence my treatment? |
| Hepatitis B | Changing treatment may affect control of this infection. | Have I been tested for hepatitis B? |
| Pregnancy or pregnancy plans | Treatment choices require consideration of the complete regimen and current clinical guidance. | Is my current treatment appropriate for my circumstances? |
| Other medicines | Drug interactions may affect treatment or increase side effects. | Could my medicines interact with my HIV treatment? |
These are discussion points, not reasons to change your medicine independently.
Why is hepatitis B testing important?
Hepatitis B is a viral infection that affects the liver. Some people have both HIV and hepatitis B.
TAF and TDF are active against hepatitis B, as are emtricitabine and lamivudine. However, changing or stopping treatment can affect hepatitis B control. In people with both infections, stopping medicines that suppress hepatitis B may trigger a flare of liver inflammation.
Your doctor should consider hepatitis B management alongside your HIV treatment.
Spegra vs Viropil Price: Does a Lower Price Mean Lower Quality?
The prices of Spegra and Viropil may vary by pharmacy, pack size, and applicable pricing.
A price difference alone cannot establish whether one medicine is safer, more effective, or better manufactured.
Consider the medicine’s composition, regulatory assessment, manufacturing quality, and suitability for your treatment. For a current price comparison, check the maximum retail price printed on each pack and confirm the price with a licensed pharmacy.
The World Health Organization has published a product assessment for an Emcure-manufactured tablet containing dolutegravir, lamivudine, and TDF. However, that assessment does not establish that Viropil is superior to Spegra or directly compare the two brands.
What Should You Ask Your HIV Doctor?
If you take Spegra or Viropil and want to understand your treatment better, start with these questions:
- Are my kidney function results normal for me?
- Do I have any bone-health concerns that could affect my treatment?
- Should I be tested for hepatitis B?
- Could my other medicines interact with my HIV treatment?
- How will we monitor whether my treatment is working?
Your doctor may use an HIV viral load test to measure the amount of HIV in your blood. A CD4 count helps assess your immune system. Other tests may be recommended based on your medical history and treatment.
Do not switch between Spegra and Viropil based on an online comparison alone. Your treatment history, test results, and other health needs must guide the decision.
Speak to an HIV Doctor Confidentially
If you are unsure why a medicine was prescribed or whether your health history affects your treatment options, a consultation with a qualified HIV doctor can help.
TAAL+ Healthcare offers HIV treatment and ART care, including confidential consultations online and at its Pune office. Contact the provider directly to confirm available services and appointments.
Conclusion: What Should You Remember About Spegra vs Viropil?
Spegra and Viropil contain different combinations of HIV medicines. Both include dolutegravir, but Spegra contains TAF and emtricitabine, while Viropil contains TDF and lamivudine.
Research generally shows more favourable kidney and bone safety markers with TAF than with TDF. However, this does not mean Spegra is automatically the better option for every patient.
Discuss your kidney health, bone health, hepatitis B status, other medicines, and treatment history with your HIV doctor to understand which treatment is appropriate for your individual needs.
Frequently Asked Questions
Is Spegra better than Viropil?
There is no direct comparative evidence identified in the sources reviewed that establishes one brand as universally superior. Their ingredients differ, so your doctor should assess which formulation suits your medical needs.
Is TAF safer than TDF for the kidneys?
TAF generally has more favourable kidney safety markers than TDF. Individual risks vary, so your kidney function and complete treatment regimen should guide decisions.
Is TAF better than TDF for bone health?
TAF-containing regimens generally show more favourable bone mineral density outcomes. This may matter for people with osteoporosis or other bone-health concerns, but it does not guarantee fewer fractures.
Does cheaper HIV medicine mean lower quality?
No. Price alone does not establish medicine quality or effectiveness. Regulatory assessments, manufacturing standards, and individual suitability are more relevant considerations.
Can I change from Spegra to Viropil?
Do not change independently. Your doctor should review your treatment history, test results, and other health needs before recommending a switch.
Medical disclaimer: This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
